TOIIW (The Oncology Institute) OCF Margin %: -1.50% (As of Mar. 2026)


TOIIW The Oncology Institute Inc TOIIW
56 GF Score
Price $0.05
! 6 Warning Signs
View Full Analysis

What is The Oncology Institute OCF Margin %?

The Oncology Institute TOIIW -16.36% 56 OCF Margin % is -1.50% as of Mar. 2026. GuruFocus rates TOIIW with a GF Score™ of 56/100. The stock has 6 warning signs investors should review. Among 668 Healthcare Providers & Services companies, The Oncology Institute ranks worse than 77.1% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. The Oncology Institute's Cash Flow from Operations for the three months ended in Mar. 2026 was $-2.22 Mil. The Oncology Institute's Revenue for the three months ended in Mar. 2026 was $147.44 Mil. Therefore, The Oncology Institute's OCF Margin % for the quarter that ended in Mar. 2026 was -1.50%.

As of today, The Oncology Institute's current OCF Yield % is 0.00%.

The historical rank and industry rank for The Oncology Institute's OCF Margin % or its related term are showing as below:


During the past 8 years, the highest OCF Margin % of The Oncology Institute was 4.99%. The lowest was -24.46%. And the median was -5.82%.

TOIIW's OCF Margin % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 8.33
* Ranked among companies with meaningful OCF Margin % only.

The Oncology Institute OCF Margin % Related Terms

The Oncology Institute OCF Margin % Historical Data

* Premium members only.

The historical data trend for The Oncology Institute's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Oncology Institute OCF Margin % Chart

The Oncology Institute Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial -16.10 -24.46 -11.20 -6.75 -4.89

The Oncology Institute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.78 -8.52 -9.25 2.28 -1.50
TOIIW
56GF Score
The Oncology Institute Inc TOIIW
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Oncology Institute OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

The Oncology Institute's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-24.587/502.729
=-4.89 %

The Oncology Institute's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-2.215/147.441
=-1.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -1.50% mean?
The Oncology Institute (TOIIW) has a OCF Margin % of -1.50% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on The Oncology Institute and its competitors. According to the industry distribution chart, The Oncology Institute ranks #515 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 77.1%.
Is The Oncology Institute's OCF Margin % too high?
The Oncology Institute's current OCF Margin % is -1.50%. Based on the distribution chart, The Oncology Institute ranks #515 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, The Oncology Institute has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does The Oncology Institute's OCF Margin % compare to CCRN and SRTA?
According to the Healthcare Providers & Services industry distribution chart, The Oncology Institute ranks #515 out of 668 companies for OCF Margin %. This places The Oncology Institute in the lower half of its industry. The industry median OCF Margin % is 8.33. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.33, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on The Oncology Institute and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Oncology Institute's current OCF Margin % is -1.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Oncology Institute stock overvalued right now?
The Oncology Institute (TOIIW) has a current OCF Margin % of -1.50%. The current OCF Margin % is -1.50%. The Oncology Institute's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For The Oncology Institute (TOIIW), the current OCF Margin % is -1.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Oncology Institute Business Description

Other Exchanges TOI:USA
Address 18000 Studebaker Road, Suite 800, Cerritos, CA, USA, 90703
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
56GF Score

Get the complete analysis for TOIIW

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price